{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:08:36Z","timestamp":1763132916601,"version":"3.45.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03405-2","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:13:41Z","timestamp":1761984821000},"page":"6313-6315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Letter Regarding: \u201cBiologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study\u201d"],"prefix":"10.1007","volume":"42","author":[{"given":"Chiara","family":"Tognaccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Ghanim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"issue":"4","key":"3405_CR1","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1007\/s12325-025-03122-w","volume":"42","author":"SR Feldman","year":"2025","unstructured":"Feldman SR, Gao R, Bohn RL, Gray S, D\u00e9ruaz-Luyet A, Wu JJ. Biologic treatment adherence and persistence in patients with palmoplantar pustulosis: a real-world, claims-based study. Adv Ther. 2025;42(4):1994\u20132002.","journal-title":"Adv Ther"},{"issue":"6","key":"3405_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/1346-8138.15826","volume":"48","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T. Similarity and difference between palmoplantar pustulosis and pustular psoriasis. J Dermatol. 2021;48(6):750\u201360.","journal-title":"J Dermatol"},{"issue":"6","key":"3405_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/1346-8138.13751","volume":"44","author":"M Kouno","year":"2017","unstructured":"Kouno M, Nishiyama A, Minabe M, et al. Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal. J Dermatol. 2017;44(6):695\u2013700.","journal-title":"J Dermatol"},{"issue":"6","key":"3405_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2340\/00015555-1552","volume":"93","author":"N Kikuchi","year":"2013","unstructured":"Kikuchi N, Yamamoto T. Dental infection as a triggering factor in palmoplantar pustulosis. Acta Derm Venereol. 2013;93(6):721\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"Suppl","key":"3405_CR5","first-page":"161","volume":"523","author":"A Kataura","year":"1996","unstructured":"Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta Otolaryngol. 1996;523(Suppl):161\u20134.","journal-title":"Acta Otolaryngol"},{"key":"3405_CR6","first-page":"135","volume":"13","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T. Guselkumab for the treatment of palmoplantar pustulosis: a Japanese perspective. Clin Pharmacol. 2021;13:135\u201343.","journal-title":"Clin Pharmacol"},{"key":"3405_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jare.2018.09.003","volume":"15","author":"L Quartuccio","year":"2018","unstructured":"Quartuccio L, Zabotti A, Del Zotto S, Zanier L, De Vita S, Valent F. Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data. J Adv Res. 2018;15:87\u201393.","journal-title":"J Adv Res"},{"issue":"1","key":"3405_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T\u00a0cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"3405_CR9","first-page":"e242","volume":"53","author":"T Hiraiwa","year":"2014","unstructured":"Hiraiwa T, Rokkaku Y, Yamamoto T. Palmoplantar pustulosis with arthro-osteitis triggered by recurrent appendiceal abscess 5\u00a0years after appendectomy. Int J Dermatol. 2014;53(12):e242\u20133.","journal-title":"Int J Dermatol"},{"issue":"1","key":"3405_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jdermsci.2020.03.003","volume":"98","author":"M Murakami","year":"2020","unstructured":"Murakami M, Terui T. Palmoplantar pustulosis: current understanding of disease definition and pathomechanism. J Dermatol Sci. 2020;98(1):13\u20139.","journal-title":"J Dermatol Sci"},{"issue":"4","key":"3405_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40257-016-0191-7","volume":"17","author":"I Raposo","year":"2016","unstructured":"Raposo I, Torres T. Palmoplantar psoriasis and palmoplantar pustulosis: current treatment and future prospects. Am J Clin Dermatol. 2016;17(4):349\u201358.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"3405_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaad.2023.04.043","volume":"89","author":"RK Spencer","year":"2023","unstructured":"Spencer RK, Jin JQ, Elhage KG, et al. Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis of randomized clinical trials. J Am Acad Dermatol. 2023;89(2):423\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3405_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5114\/ada.2024.141128","volume":"41","author":"HF Leong","year":"2024","unstructured":"Leong HF, Wang WH, Peng F. Biologics as a novel treatment option for palmoplantar pustulosis: a comprehensive review. Adv Dermatol Allergol. 2024;41(3):262\u20139.","journal-title":"Adv Dermatol Allergol"},{"issue":"2","key":"3405_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/jdv.19584","volume":"38","author":"T Bertelsen","year":"2024","unstructured":"Bertelsen T, Egeberg A, Skov L, et al. Drug survival of biologic therapies for palmoplantar pustulosis: a nationwide study. J Eur Acad Dermatol Venereol. 2024;38(2):332\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"3405_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaci.2024.05.015","volume":"154","author":"A Hernandez-Cordero","year":"2024","unstructured":"Hernandez-Cordero A, Thomas L, Smail A, et al. A genome-wide meta-analysis of palmoplantar pustulosis implicates Th2 responses and cigarette smoking in disease pathogenesis. J Allergy Clin Immunol. 2024;154(3):657-665.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3405_CR16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/all.16019","volume":"79","author":"YX Zheng","year":"2024","unstructured":"Zheng YX, Chen XB, Wang ZY, et al. Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation. Allergy. 2024;79(5):1361\u20134.","journal-title":"Allergy"},{"issue":"4","key":"3405_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","volume":"150","author":"D McCluskey","year":"2022","unstructured":"McCluskey D, Benzian-Olsson N, Mahil SK, et al. Single-cell analysis implicates Th17-to-Th2 cell plasticity in the pathogenesis of palmoplantar pustulosis. J Allergy Clin Immunol. 2022;150(4):882\u201393.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03405-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:04:30Z","timestamp":1763132670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03405-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03405-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Steven R. Feldman is an Editor-in-Chief\/Editorial Board member of\n                      Advances in Therapy\n                      . Steven R. Feldman was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Steven R. Feldman declares receiving research, speaking, and\/or consulting support from AbbVie, Accordant, Advance Medical, Almirall, Alvotech, Amgen, Arcutis, Arena Pharmaceuticals, Argenx, Biocon, Boehringer Ingelheim, Bristol Myers Squibb, Caremark, Celgene, Dermavant, Eli Lilly, Galderma, GSK\/Stiefel, Helsinn, Informa, Janssen, LeoPharma, Menlo, Merck, Mylan, NationalBiological Corporation, National Psoriasis Foundation, Novan, Novartis, Pfizer, Qurient, Regeneron, Samsung, Sanofi, Sun Pharmaceutical Industries, Suncare Research Laboratories, UCB, UpToDate, Valeant, and vTv Therapeutics. He is also the founder and majority owner of\n                      \n                      and has stock in Sensal. Jashin J. Wu declares being an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, DermTech, Dr. Reddy\u2019s Laboratories, Eli Lilly, EPI Health, Galderma, Janssen, Leo Pharma, Mindera, Novartis, Pfizer, Regeneron, Samsung Bioepis, Sanofi Genzyme, Solius, Sun Pharmaceutical Industries, UCB, and Zerigo Health. Chiara Tognaccini, Leah E. Thomas, and Dina Ghanim declare that they have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}